Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

NCT06454890 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-Small Cell Lung Cancer NSCLC

Interventions

BIOLOGICAL: Anti-Trop2 CAR-NK cell

Sponsor

Henan Cancer Hospital